94 related articles for article (PubMed ID: 22542654)
1. Synthetic biotinylated peptide compounds derived from Asp-hemolysin: novel potent inhibitors of platelet-activating factor.
Sato A; Kumagai T; Aoki J; Ebina K
Eur J Pharmacol; 2012 Jun; 685(1-3):205-12. PubMed ID: 22542654
[TBL] [Abstract][Full Text] [Related]
2. An endothelin-3-related synthetic biotinylated pentapeptide as a novel inhibitor of platelet-activating factor.
Sato A; Suzuki T; Oikawa K; Ohta R; Ebina K
Eur J Pharmacol; 2013 Aug; 714(1-3):142-7. PubMed ID: 23792041
[TBL] [Abstract][Full Text] [Related]
3. A synthetic biotinylated peptide, BP21, inhibits the induction of mRNA expression of inflammatory substances by oxidized- and lyso-phosphatidylcholine.
Sato A; Kumagai T; Ebina K
Drug Dev Res; 2014 Jun; 75(4):246-56. PubMed ID: 24890951
[TBL] [Abstract][Full Text] [Related]
4. Biotinylated heptapeptides substituted with a D-amino acid as platelet-activating factor inhibitors.
Sato A; Yokoyama I; Ebina K
Eur J Pharmacol; 2015 Oct; 764():202-207. PubMed ID: 26142829
[TBL] [Abstract][Full Text] [Related]
5. A biotinylated peptide, BP21, as a novel potent anti-anaphylactic agent targeting platelet-activating factor.
Sato A; Ebina K
J Pept Sci; 2017 Sep; 23(9):727-735. PubMed ID: 28627122
[TBL] [Abstract][Full Text] [Related]
6. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin peptides attenuate platelet-activating factor-induced inflammatory activity in rats.
Sato A; Yokoyama I; Ebina K
Peptides; 2015 Nov; 73():60-6. PubMed ID: 26348270
[TBL] [Abstract][Full Text] [Related]
8. A biotinylated peptide, BP21, alleviates hypotension in anaphylactic mice.
Sato A; Ebina K
J Pept Sci; 2019 Aug; 25(8):e3197. PubMed ID: 31264321
[TBL] [Abstract][Full Text] [Related]
9. Synthetic biotinylated peptide compound, BP21, specifically recognizes lysophosphatidylcholine micelles.
Sato A; Aoki J; Ebina K
Chem Biol Drug Des; 2012 Sep; 80(3):417-25. PubMed ID: 22591064
[TBL] [Abstract][Full Text] [Related]
10. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.
Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A
J Immunol; 1992 Dec; 149(11):3682-8. PubMed ID: 1431139
[TBL] [Abstract][Full Text] [Related]
11. Common mechanism in endothelin-3 and PAF receptor function for anti-inflammatory responses.
Sato A; Ebina K
Eur J Pharmacol; 2013 Oct; 718(1-3):30-3. PubMed ID: 24055926
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo.
Sato A; Oe K; Yamanaka H; Yokoyama I; Ebina K
Eur J Pharmacol; 2014 Dec; 745():46-51. PubMed ID: 25455842
[TBL] [Abstract][Full Text] [Related]
13. Biotinylated peptides substituted with D-amino acids with high stability as anti-anaphylactic agents targeting platelet-activating factor.
Sato A; Fukase T; Ebina K
J Pept Sci; 2022 Oct; 28(10):e3412. PubMed ID: 35437860
[TBL] [Abstract][Full Text] [Related]
14. Influence of acyl and plasmalogenic analogs of platelet activating factor on chemotaxis of human leukocytes in vitro and their inflammatory and antiinflammatory activity in vivo.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2002 Nov; 67(11):1248-52. PubMed ID: 12495421
[TBL] [Abstract][Full Text] [Related]
15. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation.
Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M
Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936
[TBL] [Abstract][Full Text] [Related]
16. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
Kassuya CA; Silvestre A; Menezes-de-Lima O; Marotta DM; Rehder VL; Calixto JB
Eur J Pharmacol; 2006 Sep; 546(1-3):182-8. PubMed ID: 16925995
[TBL] [Abstract][Full Text] [Related]
17. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
Komuro Y; Imanishi N; Uchida M; Morooka S
Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
[TBL] [Abstract][Full Text] [Related]
18. [The anti-inflammatory activity of structural analogs of the platelet-activating factor].
Melikiants AG; Kulikov VI; Koloskova EE; Kuznetsova TI; Dergousov AA; Lipatkina LIu
Farmakol Toksikol; 1991; 54(4):43-5. PubMed ID: 1786825
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the placental transfer of 3 H-acetyl-melatonin.
Klein DC
Nat New Biol; 1972 May; 237(73):117-8. PubMed ID: 4503849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
